Cargando…
Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer ha...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376958/ https://www.ncbi.nlm.nih.gov/pubmed/37509209 http://dx.doi.org/10.3390/cancers15143546 |
_version_ | 1785079397959598080 |
---|---|
author | Willems, R. A. L. Michiels, N. Lanting, V. R. Bouwense, S. van den Broek, B. L. J. Graus, M. Klok, F. A. Groot Koerkamp, B. de Laat, B. Roest, M. Wilmink, J. W. van Es, N. Mieog, J. S. D. ten Cate, H. de Vos-Geelen, J. |
author_facet | Willems, R. A. L. Michiels, N. Lanting, V. R. Bouwense, S. van den Broek, B. L. J. Graus, M. Klok, F. A. Groot Koerkamp, B. de Laat, B. Roest, M. Wilmink, J. W. van Es, N. Mieog, J. S. D. ten Cate, H. de Vos-Geelen, J. |
author_sort | Willems, R. A. L. |
collection | PubMed |
description | SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer have a high risk of developing thrombosis. However, as patients underwent immediate surgery before, the incidence of thrombosis in patients with pancreatic cancer during neoadjuvant chemotherapy is understudied. Few studies have investigated the VTE incidence in this population and it is unclear whether these patients should use perioperative thromboprophylaxis to prevent thrombosis. This narrative review summarizes the evidence that is currently available. ABSTRACT: Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an improved outcome compared to patients treated with upfront surgery. Hence, patients with PDAC are more and more frequently treated with chemotherapy in the neoadjuvant setting. PDAC patients are at a high risk of developing venous thromboembolism (VTE), which is associated with decreased survival rates. As patients with PDAC were historically offered immediate surgical resection, data on VTE incidence and associated preoperative risk factors are scarce. Current guidelines recommend primary prophylactic anticoagulation in selected groups of patients with advanced PDAC. However, recommendations for patients with (borderline) resectable PDAC treated with chemotherapy in the neoadjuvant setting are lacking. Nevertheless, the prevention of complications is crucial to maintain the best possible condition for surgery. This narrative review summarizes current literature on VTE incidence, associated risk factors, risk assessment tools, and primary thromboprophylaxis in PDAC patients treated with neoadjuvant chemo(radio)therapy. |
format | Online Article Text |
id | pubmed-10376958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103769582023-07-29 Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care Willems, R. A. L. Michiels, N. Lanting, V. R. Bouwense, S. van den Broek, B. L. J. Graus, M. Klok, F. A. Groot Koerkamp, B. de Laat, B. Roest, M. Wilmink, J. W. van Es, N. Mieog, J. S. D. ten Cate, H. de Vos-Geelen, J. Cancers (Basel) Review SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer have a high risk of developing thrombosis. However, as patients underwent immediate surgery before, the incidence of thrombosis in patients with pancreatic cancer during neoadjuvant chemotherapy is understudied. Few studies have investigated the VTE incidence in this population and it is unclear whether these patients should use perioperative thromboprophylaxis to prevent thrombosis. This narrative review summarizes the evidence that is currently available. ABSTRACT: Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an improved outcome compared to patients treated with upfront surgery. Hence, patients with PDAC are more and more frequently treated with chemotherapy in the neoadjuvant setting. PDAC patients are at a high risk of developing venous thromboembolism (VTE), which is associated with decreased survival rates. As patients with PDAC were historically offered immediate surgical resection, data on VTE incidence and associated preoperative risk factors are scarce. Current guidelines recommend primary prophylactic anticoagulation in selected groups of patients with advanced PDAC. However, recommendations for patients with (borderline) resectable PDAC treated with chemotherapy in the neoadjuvant setting are lacking. Nevertheless, the prevention of complications is crucial to maintain the best possible condition for surgery. This narrative review summarizes current literature on VTE incidence, associated risk factors, risk assessment tools, and primary thromboprophylaxis in PDAC patients treated with neoadjuvant chemo(radio)therapy. MDPI 2023-07-08 /pmc/articles/PMC10376958/ /pubmed/37509209 http://dx.doi.org/10.3390/cancers15143546 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Willems, R. A. L. Michiels, N. Lanting, V. R. Bouwense, S. van den Broek, B. L. J. Graus, M. Klok, F. A. Groot Koerkamp, B. de Laat, B. Roest, M. Wilmink, J. W. van Es, N. Mieog, J. S. D. ten Cate, H. de Vos-Geelen, J. Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title | Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title_full | Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title_fullStr | Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title_full_unstemmed | Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title_short | Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care |
title_sort | venous thromboembolism and primary thromboprophylaxis in perioperative pancreatic cancer care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376958/ https://www.ncbi.nlm.nih.gov/pubmed/37509209 http://dx.doi.org/10.3390/cancers15143546 |
work_keys_str_mv | AT willemsral venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT michielsn venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT lantingvr venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT bouwenses venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT vandenbroekblj venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT grausm venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT klokfa venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT grootkoerkampb venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT delaatb venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT roestm venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT wilminkjw venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT vanesn venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT mieogjsd venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT tencateh venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare AT devosgeelenj venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare |